Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PRTO

Proteon Therapeutics (PRTO)

Proteon Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PRTO
日付受信時刻ニュースソース見出しコード企業名
2020/01/2207 : 16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1806 : 10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1806 : 06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1622 : 01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1520 : 04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1408 : 56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1408 : 49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1408 : 48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1107 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/1003 : 43GlobeNewswire Inc.ArTara Therapeutics Completes Merger Transaction with Proteon TherapeuticsNASDAQ:PRTOProteon Therapeutics Inc
2020/01/0106 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
2020/01/0106 : 05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/2407 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/2106 : 06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/2020 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/2006 : 26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/1907 : 46Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/1720 : 03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/0520 : 04Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
2019/12/0407 : 45PR Newswire (US)Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T...NASDAQ:PRTOProteon Therapeutics Inc
2019/11/2300 : 37PR Newswire (US)Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an...NASDAQ:PRTOProteon Therapeutics Inc
2019/11/2207 : 33PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.NASDAQ:PRTOProteon Therapeutics Inc
2019/11/2207 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/2207 : 00Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/1506 : 22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/1506 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/1506 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/1420 : 04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/1307 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
2019/11/0906 : 35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRTO